Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2005
11/03/2005US20050245730 Wound healing agents; anticancer agents; cardiovascular disorders; immunostimulants
11/03/2005US20050245728 Novel purified polypeptides from Pseudomonas aeruginosa
11/03/2005US20050245727 Consisting of a four helix bundle formed of two dimerized helix-loop-helix motifs; for use in biosensing applications
11/03/2005US20050245486 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits
11/03/2005US20050245476 Introducing nucleic acid encoding a protein comprising an engineered zinc finger DNA-binding domain
11/03/2005US20050245471 Combination products for use in antitumoral treatment
11/03/2005US20050245454 Methods and compositions for impairing multiplication of HIV-1
11/03/2005US20050245453 Peptides derived from cadherin and methods of use thereof
11/03/2005US20050245451 Peptides selectively lethal to malignant and transformed mammalian cells
11/03/2005US20050245448 DTAT fusion toxin
11/03/2005US20050245447 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF), wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and multimerizing component; use in decreasing or inhibiting plasma leakage; eye disorders
11/03/2005US20050245445 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
11/03/2005US20050245443 Bacteria strain and bacteriocin produced therefrom
11/03/2005US20050245441 Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity
11/03/2005US20050245440 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
11/03/2005US20050245438 For detecting, in the body of a human being, tumors having SSTR4 and their metastases in tissues, useful in drug-screening
11/03/2005US20050245437 Peptides having antimicrobial properties and compositions containing them, notably for the preservation of foodstuffs
11/03/2005US20050245431 Membrane, device and method for removing proteases from liquids
11/03/2005US20050244969 Transient immortalization
11/03/2005US20050244968 polynucleotides that encode plant transcription factors; using such constructs in modulating the expression of endogenous and/or heterologous genes; transgenic plants; modifying plant phenotypes
11/03/2005US20050244938 Manzamine-producing actinomycetes
11/03/2005US20050244935 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
11/03/2005US20050244931 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders
11/03/2005US20050244930 IL-21 antagonists
11/03/2005US20050244927 Process for producing polypeptides
11/03/2005US20050244925 Proteases from gram-positive organisms
11/03/2005US20050244924 Methods and constructs for high yield expression of clostripain
11/03/2005US20050244922 Bacillus host cell
11/03/2005US20050244921 Fluorescent protein variants and methods for making same
11/03/2005US20050244889 For selectively inhibiting signal transduction pathways using an active fragment of a p/CIP polypeptide or a nucleic acid molecule encoding such active fragment of a p/CIP polypeptide or a nucleic acid molecule encoding such an acive fragment
11/03/2005US20050244888 Antibodies to human chemokine beta-9
11/03/2005US20050244877 Splice variants of CD40-receptor
11/03/2005US20050244876 Human tumor necrosis factor receptors TR13 and TR14
11/03/2005US20050244868 Ten-M3 polypeptides and polynucleotides and their methods of use
11/03/2005US20050244867 Growth factor HTTER36
11/03/2005US20050244861 Nucleic acids essential for expression of hyphal-specific genes and methods for using the same
11/03/2005US20050244859 Cell based assay
11/03/2005US20050244857 Death domain containing receptor 4
11/03/2005US20050244856 Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3
11/03/2005US20050244852 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/03/2005US20050244849 Screening assays for rheumatoid arthritis
11/03/2005US20050244845 90 human secreted proteins
11/03/2005US20050244844 serine/threonine phosphatases (PP1); immobilization, screening
11/03/2005US20050244839 Granulin-epithelin precursor (GEP) overexpression as a target for diagnosis, prognosis and treatment of hepatocellular carcinoma (HCC)
11/03/2005US20050244834 Single nucleotide polymorphisms in genes
11/03/2005US20050244832 Class II cytokine receptor-7
11/03/2005US20050244829 Method of screening insulin resistance inproving drug
11/03/2005US20050244826 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
11/03/2005US20050244823 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
11/03/2005US20050244819 Assay system for screening protease inhibitors
11/03/2005US20050244817 Mammalian genes involved in viral infection and tumor suppression
11/03/2005US20050244806 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases
11/03/2005US20050244507 For treatment of organ or tissue hypertrophy; inducible in post-oestrus sheep by clomiphene
11/03/2005US20050244437 Live antenuated parasite vaccine
11/03/2005US20050244436 Combination Neisserial compositions
11/03/2005US20050244435 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis
11/03/2005US20050244434 Tat-based tolerogen compositions and methods of making and using same
11/03/2005US20050244433 Administering vaccine comprising human papillomavirus L1 protein and excludes E protein to induce immune response
11/03/2005US20050244432 Expression of an L1 protein or functional protein derivative from two different types of papillomaviruses, and mixing the two; used for the prevention or treatment of a disease related to papillomavirus infection, such as cervical cancer or genital warts
11/03/2005US20050244430 Orthopoxvirus vectors, genes and products thereof
11/03/2005US20050244429 Live replicating spumavirus vector
11/03/2005US20050244428 Site-directed mutagenesis; plasmid vectors; Dengue virus
11/03/2005US20050244425 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
11/03/2005US20050244424 Carbohydrate-based synthetic vaccines for hiv
11/03/2005US20050244423 administering to mammals genetic engineered or pegylated polypeptides, to reduce liver inflammation associated with viral infections
11/03/2005US20050244422 Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress
11/03/2005US20050244421 Compositions and methods for modulating immune response
11/03/2005US20050244417 Using mixture comprising human estrogen specific immunoglobulin and tumor necrosis factor related apoptosis inducing ligand (APO-2L) for use as tool to enhance apoptosis in cancer cells
11/03/2005US20050244411 BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
11/03/2005US20050244408 gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-IGF-IR antibodies; colorectal or breast cancer tumor
11/03/2005US20050244405 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
11/03/2005US20050244376 Modified viral surface proteins for binding to extracellular matrix components
11/03/2005US20050244374 Enveloped miroorganism
11/03/2005US20050244372 Interleukin-3 (IL-3) multiple mutation polypeptides
11/03/2005US20050244370 Selective local activation of members of the TNF receptor family by systemically inactive non-antibody TNF ligand fusion proteins
11/03/2005CA2564594A1 Generation of plants with altered oil content
11/03/2005CA2564453A1 Peptide inhibitors of metalloproteinase activity
11/03/2005CA2564031A1 Method for the purification of albumin conjugates
11/03/2005CA2563943A1 Nucleotide sequences and polypeptides encoded thereby useful for modifying nitrogen use efficiency characteristics in plants
11/03/2005CA2563874A1 Erythropoietin protein variants
11/03/2005CA2563754A1 Recombinant polypeptides of the members of the tnf ligand family and use thereof
11/03/2005CA2563614A1 Tlr ligand and il-1 response-injured animal model
11/03/2005CA2562764A1 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
11/03/2005CA2561065A1 Therapeutic use of anti-cs1 antibodies
11/03/2005CA2560074A1 Combinatorial protein library screening by periplasmic expression
11/03/2005CA2551643A1 Metal-containing nanolayered composites, and applications thereof
11/02/2005EP1591791A2 Diagnostic assay for human matrix gla-protein and its use as a biomarker
11/02/2005EP1591790A2 Method and reagents for determining protein S.
11/02/2005EP1591539A1 NS5A nucleoside sequence variation as a marker
11/02/2005EP1591537A2 Hereditary hemochromatosis gene
11/02/2005EP1591530A2 A tumor necrosis factor related ligand
11/02/2005EP1591529A2 Human CLTA-8 and uses of CTLA-8-related proteins
11/02/2005EP1591528A2 Method and compositions for delivery and expression of interferon-alpha nucleic acids
11/02/2005EP1591526A2 Frazzled nucleotide sequences, expression products, compositions and uses
11/02/2005EP1591520A2 Microorganism producing L-threonine having inactivated tyR gene, method of producing the same and method of producing L-threonine using the microorganism
11/02/2005EP1591518A1 Process and device for preparing phycoerythrin with high od ratio
11/02/2005EP1591455A1 Essential tremor diagnostic and treatment
11/02/2005EP1591454A1 Novel lysophosphatidic acid receptor
11/02/2005EP1591453A1 Modified peptides yy and conjugates thereof
11/02/2005EP1591452A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 ... 2916